Chairs:

• Lorenza Rimassa, Director of the Residency School of Medical Oncology, Humanitas University, Deputy Director, Medical Oncology Unit. Head, Gastrointestinal Oncology. Humanitas Cancer Center, Humanitas Research Hospital, Milan, Italy

• Andrew Zhu, Director of Jiahui International Cancer Center, Director Emeritus of Liver Cancer Research at Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School, US

Agenda:

• Pathology of CCA presented by Valerie Paradis, Professor in Pathology, chairman of Pathology department (Beaujon hospital) and leader of the INSERM team ‘From inflammation to neoplasia in digestive diseases’ (INSERM UMR 1149 Paris), France

• Molecular characterization, actionable genetic alterations presented by Maeve Lowery, Professor of Translational Cancer Medicine at Trinity College Dublin and Consultant Medical Oncologist at St James Hospital, Ireland

• Targeted therapies including immunotherapy given recent promising early phase data with lenva-pembro or IO+chemo and ongoing phase 2-3 trials presented by Lipika Goyal, Gastrointestinal Medical Oncologist at Massachusetts General Hospital Cancer Center, USA